BACKGROUND & AIMS: Ethanol abuse can lead to hepatic steatosis and evolve into cirrhosis and hepatocellular carcinoma. Pigment epithelium-derived factor (PEDF) is a multifunctional secreted glycoprotein that is expressed by hepatocytes. Proteomic, experimental, and clinical studies implicate PEDF's role in lipid regulation. Because matrix metalloproteinase (MMP)-2/9 activity regulates PEDF levels, we investigated whether PEDF degradation by MMPs has a permissive role in ethanol-induced hepatic steatosis. METHODS: PEDF levels were examined in liver biopsy specimens from patients with ethanol-induced steatosis. Hepatic PEDF levels and MMP activity were assessed in 2 animal models of ethanol feeding (rats on an alcohol-containing liquid diet and mice given intragastric infusion of ethanol). The consequences of PEDF depletion in the liver were examined in PEDF-null mice. RESULTS: Liver biopsy samples from patients with ethanol-induced steatosis had reduced PEDF levels, compared with normal liver samples. Ethanol-fed animals had histologic steatosis and increased liver triglyceride content (P< .05), as well as reduced levels of hepatic PEDF and increased MMP-2/9 activity. Ethanol-exposed hepatic lysates degraded PEDF in a MMP-2/9-dependent manner, and liver sections demonstrated abundant MMP-2/9 activity in situ. Addition of recombinant PEDF to PEDF-null hepatocytes, reduced their triglyceride content. CONCLUSIONS: Ethanol exposure leads to marked loss of hepatic PEDF in human livers and in 2 animal models of ethanol feeding. Loss of PEDF contributes to the accumulation of lipids in ethanol-induced hepatic steatosis.
BACKGROUND & AIMS:Ethanol abuse can lead to hepatic steatosis and evolve into cirrhosis and hepatocellular carcinoma. Pigment epithelium-derived factor (PEDF) is a multifunctional secreted glycoprotein that is expressed by hepatocytes. Proteomic, experimental, and clinical studies implicate PEDF's role in lipid regulation. Because matrix metalloproteinase (MMP)-2/9 activity regulates PEDF levels, we investigated whether PEDF degradation by MMPs has a permissive role in ethanol-induced hepatic steatosis. METHODS:PEDF levels were examined in liver biopsy specimens from patients with ethanol-induced steatosis. Hepatic PEDF levels and MMP activity were assessed in 2 animal models of ethanol feeding (rats on an alcohol-containing liquid diet and mice given intragastric infusion of ethanol). The consequences of PEDF depletion in the liver were examined in PEDF-null mice. RESULTS: Liver biopsy samples from patients with ethanol-induced steatosis had reduced PEDF levels, compared with normal liver samples. Ethanol-fed animals had histologic steatosis and increased liver triglyceride content (P< .05), as well as reduced levels of hepatic PEDF and increased MMP-2/9 activity. Ethanol-exposed hepatic lysates degraded PEDF in a MMP-2/9-dependent manner, and liver sections demonstrated abundant MMP-2/9 activity in situ. Addition of recombinant PEDF to PEDF-null hepatocytes, reduced their triglyceride content. CONCLUSIONS:Ethanol exposure leads to marked loss of hepatic PEDF in human livers and in 2 animal models of ethanol feeding. Loss of PEDF contributes to the accumulation of lipids in ethanol-induced hepatic steatosis.
Authors: Irina Kratchmarova; Dario E Kalume; Blagoy Blagoev; Philipp E Scherer; Alexandre V Podtelejnikov; Henrik Molina; Perry E Bickel; Jens S Andersen; Minerva M Fernandez; Jacob Bunkenborg; Peter Roepstorff; Karsten Kristiansen; Harvey F Lodish; Matthias Mann; Akhilesh Pandey Journal: Mol Cell Proteomics Date: 2002-03 Impact factor: 5.911
Authors: Meena B Bansal; Kellen Kovalovich; Ritu Gupta; Wei Li; Akansha Agarwal; Brian Radbill; Carlos E Alvarez; Rifaat Safadi; M Isabel Fiel; Scott L Friedman; Rebecca A Taub Journal: J Hepatol Date: 2005-04 Impact factor: 25.083
Authors: A J Jenkins; S X Zhang; K G Rowley; C S Karschimkus; C L Nelson; J S Chung; D N O'Neal; A S Januszewski; K D Croft; T A Mori; G Dragicevic; C A Harper; J D Best; T J Lyons; J-X Ma Journal: Diabet Med Date: 2007-10-29 Impact factor: 4.359
Authors: Chuhan Chung; Jennifer A Doll; Arijeet K Gattu; Christine Shugrue; Mona Cornwell; Philip Fitchev; Susan E Crawford Journal: J Hepatol Date: 2007-12-26 Impact factor: 25.083
Authors: Arijeet K Gattu; Andreas L Birkenfeld; Yasuko Iwakiri; Steven Jay; Mark Saltzman; Jennifer Doll; Petr Protiva; Varman T Samuel; Susan E Crawford; Chuhan Chung Journal: Endocrinology Date: 2014-01-23 Impact factor: 4.736
Authors: Harshica Fernando; Shakuntala Kondraganti; Kamlesh K Bhopale; David E Volk; Muniasamy Neerathilingam; Bhupendra S Kaphalia; Bruce A Luxon; Paul J Boor; G A Shakeel Ansari Journal: Alcohol Clin Exp Res Date: 2010-11 Impact factor: 3.455
Authors: Arijeet K Gattu; E Scott Swenson; Yasuko Iwakiri; Varman T Samuel; Nancy Troiano; Ryan Berry; Christopher D Church; Matthew S Rodeheffer; Thomas O Carpenter; Chuhan Chung Journal: FASEB J Date: 2013-07-25 Impact factor: 5.191
Authors: John C Schmitz; Petr Protiva; Arijeet K Gattu; Teruo Utsumi; Yasuko Iwakiri; Antonio G Neto; Margo Quinn; Mona L Cornwell; Philip Fitchev; Aurelia Lugea; Susan E Crawford; Chuhan Chung Journal: Am J Pathol Date: 2011-09-28 Impact factor: 4.307
Authors: Glenn S Belinsky; Bharath Sreekumar; Jillian W Andrejecsk; W Mark Saltzman; Jingjing Gong; Raimund I Herzog; Samantha Lin; Valerie Horsley; Thomas O Carpenter; Chuhan Chung Journal: FASEB J Date: 2016-04-28 Impact factor: 5.191
Authors: Bharath K Sreekumar; Glenn S Belinsky; Henrik Einwachter; Andrew D Rhim; Roland Schmid; Chuhan Chung Journal: Pancreas Date: 2014-11 Impact factor: 3.327